Differential use of antidiabetic medication related to income, cohabitation and area of residence: a Swedish nationwide cohort study
Open Access
- 26 February 2025
- journal article
- Published by BMJ in Journal of Epidemiology and Community Health
- Vol. 79 (8) , 571-579
Abstract
Background Poor adherence to antidiabetic medication in individuals with type 2 diabetes (T2D) may lead to increased risk of morbidity and mortality. Socioeconomic and demographic factors associated with non-adherence have been mainly identified via cross-sectional studies. To investigate the association between antidiabetic medication adherence and income, cohabitation and area of residence. Methods Register-based cohort study of individuals with T2D living in Sweden and initiating antidiabetic treatment between 2006 and 2022. Confounding adjustment and competing events were accounted for via inverse probability of treatment and censoring weighting. Exposures were disposable income, social income support, cohabitation status and area of residence. Outcomes were antidiabetic medication adherence during the first year from treatment initiation and treatment interruption at 12 and 60 months. Results This study included 594 918 individuals with T2D. Low disposable income (adjusted OR: 1.18, 95% CI: (1.14 to 1.21)), social income support (1.09, (1.05 to 1.14)), living in large cities (1.28, (1.24 to 1.31)) and cohabitation (1.09, (1.06 to 1.11)) were associated with non-adherence (proportion of days covered ≤0.2), as compared with high adherence (proportion of days covered >0.8). Consistently, treatment interruption was associated with social income support (relative risk ratio at 12 months: 1.10, (1.06 to 1.14) and at 60 months 1.02 (1.00 to 1.05)), living in large cities (1.13, (1.12 to 1.14); 1.08, (1.07 to 1.08)) and low income (1.05, (1.03 to 1.07); 1.01, (1.00 to 1.02)). Conclusions Low income levels, cohabitation and living in large cities were associated with non-adherence to antidiabetic medication and risk of treatment interruption. The results highlight the need for targeted interventions aiming at improving adherence to treatments both at patient and healthcare system levels.Keywords
Funding Information
- Karolinska Institutet Foundation and Funds (2020-01343)
- Strategic Research Programme (SRP) in Diabetes at Karolinska Institutet (2022)
- FORTE Swedish Research Council for Health, Working Life, and Welfare (2021-01080)
This publication has 30 references indexed in Scilit:
- Socioeconomic factors associated with poor medication adherence in patients with type 2 diabetesEuropean Journal of Clinical Pharmacology, 2023
- Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: A simulation studyPharmacoepidemiology and Drug Safety, 2021
- The role of socioeconomic factors on discontinuation of insulin during pregnancy—methodological challenges from a Swedish register-based studyJournal of Public Health, 2020
- Metformin adherence and discontinuation among patients with type 2 diabetes: A retrospective cohort studyJournal of Clinical & Translational Endocrinology, 2020
- A causal framework for classical statistical estimands in failure‐time settings with competing eventsStatistics in Medicine, 2020
- Adherence to metformin monotherapy in people with type 2 diabetes mellitus in New ZealandDiabetes Research and Clinical Practice, 2019
- Methods for constructing treatment episodes and impact on exposure-outcome associationsEuropean Journal of Clinical Pharmacology, 2019
- Cultural issues and other factors that affect self-management of Type 2 Diabetes Mellitus (T2D) by Chinese immigrants in AustraliaDiabetes Research and Clinical Practice, 2016
- Adherence to diabetes medication: a systematic reviewDiabetic Medicine, 2015
- Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes MellitusArchives of internal medicine (1960), 2006